This new tool improves the accuracy of the Framingham Risk Score but retains its simplicity.
M any factors increase the risk for coronary heart disease. More than 40 years ago, investigators with the Framingham Heart Study identified several key risk factors. About 10 years ago, they used this knowledge to develop a tool to predict heart disease risk. Variations exist, but one version of the Framingham Risk Score relies on six items-age, gender, total cholesterol, HDL cholesterol, smoking status, and systolic blood pressure-to estimate one's risk of having a first heart attack or being diagnosed with heart disease in the next 10 years. A risk greater than 20% is considered high; 10% to 20% is intermediate to high; 5% to less than 10% is low to intermediate; and less than 5% is very low.
An accurate assessment of cardiovascular risk is critical in helping clinicians determine which prevention strategies to recommend for individual patients. Striving for a heart-healthy lifestyle (e.g., avoiding saturated and trans fats, getting regular physical activity, and not smoking) is important for everyone regardless of risk level, and sufficient for those at low risk. Aspirin or medications that favorably affect cholesterol levels and blood pressure are likely to be helpful for individuals at intermediate cardiovascular risk and are definitely recommended for those at high risk.
Although 
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Harvard Medical School in Boston, led by Paul Ridker, MD, MPH, and Nancy Cook, ScD, sought to develop a new tool to improve the accuracy of the Framingham Risk Score but retain its simplicity.They used health data from more than 24,000 female health professionals who had contributed a baseline blood sample and been followed for many years in the Women's Health Study (WHS; http://whs.bwh.harvard. edu). First, the researchers compiled a list of three dozen potential risk factors for heart disease and stroke. The list included the traditional risk factors identified by the Framingham research team four decades ago as well as novel risk factors discovered by WHS and other investigators more recently. Next, they entered the values for each of these risk factors from 16,000 of the aforementioned participants into a computer model to determine which combination of factors would best predict whether these individuals would go on to develop a heart attack, stroke, or other cardiovascular event during 10 years of follow-up.
Seven factors emerged as most predictive: age, smoking, systolic blood pressure, C-reactive protein (CRP) , having a parent who developed heart disease before age 60, apolipoprotein B, and apolipoprotein A-I. Apolipoprotein B and apolipoprotein A-I are highly correlated with total cholesterol and HDL cholesterol, respectively, so the researchers chose to use the latter, more widely accepted measures instead. These substitutions make the new tool nearly as simple to use as the Framingham Risk Score in that only one additional blood test (for CRP) is required.
Finally, the researchers tested the tool on the remaining 8,000 participants. It did as well as the Fram-ingham Risk Score for women in the lowest and highest risk groups but outperformed the Framingham Risk Score for those in the middle two risk groups, reassigning nearly half these women to higher or lower risk categories. The new classifications better predicted whether these women actually developed heart disease or stroke during the next 10 years.
'The new tool, dubbed the Reynolds Risk Score after the foundation that funded this research, contains all the factors deemed important 40 years ago from the Framingham Heart Study, plus two measures that represent major advances in our understanding of the origins of cardiovascular disease," said Dr. Ridker. 'The inclusion of CRP reflects the fact that inflammation is intimately linked to cardiovascular disease. The inclusion of family history signifies the importance of genetics." "Our hope is that, by more accurately classifying patients with respect to cardiovascular risk group, clinicians will be better able to target the use of aspirin or cholesterol-lowering medications," he added.
The February 14, 2007, issue of the JournaL of the American Medi-caL Association reports more about the development of the Reynolds Risk Score. Women can calculate their Reynolds Risk Score by accessing www.reynoldsriskscore.org and their Framingham Risk Score by accessing http://hin.nhlbLnih.gov/ atpiiilcalculator.asp. Although low cardiovascular risk is reassuring, it is not carte blanche to abandon--or refrain from adopting-heart-healthy habits. Framingham Heart Study findings suggest that even 50-yearold women in good cardiovascular health have a 40% risk of developing heart disease later in life. Vigilance in monitoring and controlling risk factors will decrease the odds of heart disease development with age.
